Epigenetic mechanisms in respiratory muscle dysfunction of patients with chronic obstructive pulmonary disease.

Epigenetic events are differentially expressed in the lungs and airways of patients with chronic obstructive pulmonary disease (COPD). Moreover, epigenetic mechanisms are involved in the skeletal (peripheral) muscle dysfunction of COPD patients. Whether epigenetic events may also regulate respirator...

Full description

Bibliographic Details
Main Authors: Ester Puig-Vilanova, Rafael Aguiló, Alberto Rodríguez-Fuster, Juana Martínez-Llorens, Joaquim Gea, Esther Barreiro
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4219759?pdf=render
id doaj-8cfce273e3c74a22b73d154bdb08202b
record_format Article
spelling doaj-8cfce273e3c74a22b73d154bdb08202b2020-11-25T02:25:02ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01911e11151410.1371/journal.pone.0111514Epigenetic mechanisms in respiratory muscle dysfunction of patients with chronic obstructive pulmonary disease.Ester Puig-VilanovaRafael AguilóAlberto Rodríguez-FusterJuana Martínez-LlorensJoaquim GeaEsther BarreiroEpigenetic events are differentially expressed in the lungs and airways of patients with chronic obstructive pulmonary disease (COPD). Moreover, epigenetic mechanisms are involved in the skeletal (peripheral) muscle dysfunction of COPD patients. Whether epigenetic events may also regulate respiratory muscle dysfunction in COPD remains unknown. We hypothesized that epigenetic mechanisms would be differentially expressed in the main inspiratory muscle (diaphragm) of patients with COPD of a wide range of disease severity compared to healthy controls. In diaphragm muscle specimens (thoracotomy due to lung localized neoplasms) of sedentary patients with mild-to-moderate and severe COPD, with preserved body composition, and sedentary healthy controls, expression of muscle-enriched microRNAs, histone acetyltransferases (HATs) and deacetylases (HDACs), total DNA methylation and protein acetylation, small ubiquitin-related modifier (SUMO) ligases, muscle-specific transcription factors, and muscle structure were explored. All subjects were also clinically evaluated: lung and muscle functions and exercise capacity. Compared to healthy controls, patients exhibited moderate airflow limitation and diffusion capacity, and reduced exercise tolerance and transdiaphragmatic strength. Moreover, in the diaphragm of the COPD patients, muscle-specific microRNA expression was downregulated, while HDAC4 and myocyte enhancer factor (MEF)2C protein levels were higher, and DNA methylation levels, muscle fiber types and sizes did not differ between patients and controls. In the main respiratory muscle of COPD patients with a wide range of disease severity and normal body composition, muscle-specific microRNAs were downregulated, while HDAC4 and MEF2C levels were upregulated. It is likely that these epigenetic events act as biological adaptive mechanisms to better overcome the continuous inspiratory loads of the respiratory system in COPD. These findings may offer novel therapeutic strategies to specifically target respiratory muscle dysfunction in patients with COPD.http://europepmc.org/articles/PMC4219759?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Ester Puig-Vilanova
Rafael Aguiló
Alberto Rodríguez-Fuster
Juana Martínez-Llorens
Joaquim Gea
Esther Barreiro
spellingShingle Ester Puig-Vilanova
Rafael Aguiló
Alberto Rodríguez-Fuster
Juana Martínez-Llorens
Joaquim Gea
Esther Barreiro
Epigenetic mechanisms in respiratory muscle dysfunction of patients with chronic obstructive pulmonary disease.
PLoS ONE
author_facet Ester Puig-Vilanova
Rafael Aguiló
Alberto Rodríguez-Fuster
Juana Martínez-Llorens
Joaquim Gea
Esther Barreiro
author_sort Ester Puig-Vilanova
title Epigenetic mechanisms in respiratory muscle dysfunction of patients with chronic obstructive pulmonary disease.
title_short Epigenetic mechanisms in respiratory muscle dysfunction of patients with chronic obstructive pulmonary disease.
title_full Epigenetic mechanisms in respiratory muscle dysfunction of patients with chronic obstructive pulmonary disease.
title_fullStr Epigenetic mechanisms in respiratory muscle dysfunction of patients with chronic obstructive pulmonary disease.
title_full_unstemmed Epigenetic mechanisms in respiratory muscle dysfunction of patients with chronic obstructive pulmonary disease.
title_sort epigenetic mechanisms in respiratory muscle dysfunction of patients with chronic obstructive pulmonary disease.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description Epigenetic events are differentially expressed in the lungs and airways of patients with chronic obstructive pulmonary disease (COPD). Moreover, epigenetic mechanisms are involved in the skeletal (peripheral) muscle dysfunction of COPD patients. Whether epigenetic events may also regulate respiratory muscle dysfunction in COPD remains unknown. We hypothesized that epigenetic mechanisms would be differentially expressed in the main inspiratory muscle (diaphragm) of patients with COPD of a wide range of disease severity compared to healthy controls. In diaphragm muscle specimens (thoracotomy due to lung localized neoplasms) of sedentary patients with mild-to-moderate and severe COPD, with preserved body composition, and sedentary healthy controls, expression of muscle-enriched microRNAs, histone acetyltransferases (HATs) and deacetylases (HDACs), total DNA methylation and protein acetylation, small ubiquitin-related modifier (SUMO) ligases, muscle-specific transcription factors, and muscle structure were explored. All subjects were also clinically evaluated: lung and muscle functions and exercise capacity. Compared to healthy controls, patients exhibited moderate airflow limitation and diffusion capacity, and reduced exercise tolerance and transdiaphragmatic strength. Moreover, in the diaphragm of the COPD patients, muscle-specific microRNA expression was downregulated, while HDAC4 and myocyte enhancer factor (MEF)2C protein levels were higher, and DNA methylation levels, muscle fiber types and sizes did not differ between patients and controls. In the main respiratory muscle of COPD patients with a wide range of disease severity and normal body composition, muscle-specific microRNAs were downregulated, while HDAC4 and MEF2C levels were upregulated. It is likely that these epigenetic events act as biological adaptive mechanisms to better overcome the continuous inspiratory loads of the respiratory system in COPD. These findings may offer novel therapeutic strategies to specifically target respiratory muscle dysfunction in patients with COPD.
url http://europepmc.org/articles/PMC4219759?pdf=render
work_keys_str_mv AT esterpuigvilanova epigeneticmechanismsinrespiratorymuscledysfunctionofpatientswithchronicobstructivepulmonarydisease
AT rafaelaguilo epigeneticmechanismsinrespiratorymuscledysfunctionofpatientswithchronicobstructivepulmonarydisease
AT albertorodriguezfuster epigeneticmechanismsinrespiratorymuscledysfunctionofpatientswithchronicobstructivepulmonarydisease
AT juanamartinezllorens epigeneticmechanismsinrespiratorymuscledysfunctionofpatientswithchronicobstructivepulmonarydisease
AT joaquimgea epigeneticmechanismsinrespiratorymuscledysfunctionofpatientswithchronicobstructivepulmonarydisease
AT estherbarreiro epigeneticmechanismsinrespiratorymuscledysfunctionofpatientswithchronicobstructivepulmonarydisease
_version_ 1724853094968197120